SCHEDULE 13D/A

Company

Marker Therapeutics, Inc.

Filed

August 25, 2017

Accession Number

0001408408-17-000023

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →